Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Metabolites
Auteurs principaux: Fernandes, Anna Maria A.P., Messias, Marcia C.F., Duarte, Gustavo H.B., de Santis, Gabrielle K.D., Mecatti, Giovana C., Porcari, Andreia M., Murgu, Michael, Simionato, Ana Valéria C., Rocha, Thalita, Martinez, Carlos A.R., Carvalho, Patricia O.
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7345851/
https://ncbi.nlm.nih.gov/pubmed/32630389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10060262
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires